COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Rebecca Forman(London School of Economics and Political Science), Elías Mossialos(Imperial College London), Mark Jit(London School of Hygiene & Tropical Medicine), Patrick Jeurissen(Radboud University Nijmegen), Soleil Shah(Stanford University)
Cited by 315
Related Papers
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
|The Lancet Global Health|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
The primary health-care system in China
|The Lancet|2017|1.1k
European Society of Cardiology: Cardiovascular Disease Statistics 2019
|European Heart Journal|2019|1k
Quality of primary health care in China: challenges and recommendations
|The Lancet|2020|919